AVAH vs PNTG vs ADUS

For growth investors, The Pennant Group, Inc.

(PNTG) is the stronger pick with 36. 3% revenue growth year-over-year, versus 20. 2% for Aveanna Healthcare Holdings Inc. (AVAH). Aveanna Healthcare Holdings Inc. (AVAH) offers the better valuation at 6. 6x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate The Pennant Group, Inc. (PNTG) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Aveanna Healthcare Holdings Inc.

(AVAH) is the cheapest at 6. 6x versus The Pennant Group, Inc. at 42. 5x. On forward P/E, Aveanna Healthcare Holdings Inc. is actually cheaper at 12. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Addus HomeCare Corporation wins at 0. 70x versus The Pennant Group, Inc. 's 2. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Addus HomeCare Corporation (ADUS) delivered a total return of +0.

0%, compared to -39. 8% for Aveanna Healthcare Holdings Inc. (AVAH). Over 10 years, the gap is even starker: ADUS returned +399. 9% versus AVAH's -42. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Addus HomeCare Corporation (ADUS) is the lower-risk stock at 0.

58β versus Aveanna Healthcare Holdings Inc. 's 1. 40β — meaning AVAH is approximately 144% more volatile than ADUS relative to the S&P 500. On balance sheet safety, Addus HomeCare Corporation (ADUS) carries a lower debt/equity ratio of 19% versus 7% for Aveanna Healthcare Holdings Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), The Pennant Group, Inc.

(PNTG) is pulling ahead at 36. 3% versus 20. 2% for Aveanna Healthcare Holdings Inc. (AVAH). On earnings-per-share growth, the picture is similar: Aveanna Healthcare Holdings Inc. grew EPS 1952% year-over-year, compared to 18. 3% for The Pennant Group, Inc.. Over a 3-year CAGR, PNTG leads at 26. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Aveanna Healthcare Holdings Inc.

(AVAH) is the more profitable company, earning 9. 2% net margin versus 3. 1% for The Pennant Group, Inc. — meaning it keeps 9. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVAH leads at 10. 9% versus 5. 4% for PNTG. At the gross margin level — before operating expenses — AVAH leads at 33. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Addus HomeCare Corporation (ADUS) is the more undervalued stock at a PEG of 0. 70x versus The Pennant Group, Inc. 's 2. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Aveanna Healthcare Holdings Inc. (AVAH) trades at 12. 0x forward P/E versus 27. 0x for The Pennant Group, Inc. — 15. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVAH: 58. 5% to $11. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Addus HomeCare Corporation (ADUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

58), +399. 9% 10Y return). Both have compounded well over 10 years (ADUS: +399. 9%, AVAH: -42. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.